Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;130(12):2768-72.
doi: 10.1038/jid.2010.214. Epub 2010 Jul 29.

Carriers of rare missense variants in IFIH1 are protected from psoriasis

Yonghong Li  1 , Wilson Liao, Michele Cargill, Monica Chang, Nori Matsunami, Bing-Jian Feng, Annie Poon, Kristina P Callis-Duffin, Joseph J Catanese, Anne M Bowcock, Mark F Leppert, Pui-Yan Kwok, Gerald G Krueger, Ann B Begovich
Affiliations

Carriers of rare missense variants in IFIH1 are protected from psoriasis

Yonghong Li et al. J Invest Dermatol. 2010 Dec.

Abstract

Testing of ∼25,000 putative functional single-nucleotide polymorphisms (SNPs) across the human genome in a genetic association study has identified three psoriasis genes, IL12B, IL23R, and IL13. We now report evidence for the association of psoriasis risk with missense SNPs in the interferon induced with helicase C domain 1 gene (IFIH1). The rare alleles of two independent SNPs were associated with decreased risk of psoriasis--rs35667974 (Ile923Val): odds ratio (OR) for minor allele carriers is 0.43, P=2.36 × 10(-5) (2,098 cases vs. 1,748 controls); and rs10930046 (His460Arg): OR for minor allele carriers is 0.51, P=6.47 × 10(-4) (2,098 cases vs. 1,744 controls). Compared to noncarriers, carriers of the 923Val and/or 460Arg variants were protected from psoriasis (OR=0.46, P=5.56 × 10(-8)). To our knowledge, these results suggest that IFIH1 is a previously unreported psoriasis gene.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

Authors affiliated with Celera declare their interest in the company for employment and/or stock ownership.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Anderegg U, Breitschwerdt K, Kohler MJ, Sticherling M, Haustein UF, Simon JC, et al. MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokines. Exp Dermatol. 2005;14:709–18. - PubMed
    1. Besch R, Poeck H, Hohenauer T, Senft D, Hacker G, Berking C, et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest. 2009;119:2399–411. - PMC - PubMed
    1. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol. 2005;5:699–711. - PubMed
    1. Campalani E, Barker JNWN. The clincal genetics of psoriasis. Curr Genomics. 2005;6:51–60.
    1. Capon F, Bijlmakers MJ, Wolf N, Quaranta M, Huffmeier U, Allen M, et al. Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum Mol Genet. 2008;17:1938–1945. - PMC - PubMed

Publication types

Substances